The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis

Background: The drug 5-aminosalicylic acid (5-ASA) is the first-line therapy for the treatment of patients with mild-to-moderate ulcerative colitis (UC). However, in some cases, 5-ASA cannot achieve the desired therapeutic effects. Therefore, patients have to undergo therapies that include corticost...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Long, Wen, Shuting, Zhong, Zhuotai, Weng, Senhui, Jiang, Qilong, Mi, Hong, Liu, Fengbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176098/
https://www.ncbi.nlm.nih.gov/pubmed/34093178
http://dx.doi.org/10.3389/fphar.2021.625543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176098/
https://www.ncbi.nlm.nih.gov/pubmed/34093178
http://dx.doi.org/10.3389/fphar.2021.625543

Ejemplares similares